Haemonetics Corporation (HAE)

Operating return on assets (Operating ROA)

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating income	US$ in thousands	164,883	156,033	80,750	89,747	103,351
Total assets	US$ in thousands	2,195,590	1,934,820	1,859,730	1,819,920	1,267,110
Operating ROA		7.51%	8.06%	4.34%	4.93%	8.16%

March 31, 2024 calculation

Operating ROA = Operating income ÷ Total assets
= $164,883K ÷ $2,195,590K
= 7.51%

Haemonetics Corporation's operating return on assets (operating ROA) has fluctuated over the past five years. In the latest fiscal year ending March 31, 2024, the operating ROA stood at 7.51%, a slight decrease from 8.06% in the previous year. This decline may indicate a decrease in the company's ability to generate operating income relative to its total assets compared to the prior year.

Looking back further, the operating ROA was 4.34% in 2022 and 4.93% in 2021 before increasing to 8.16% in 2020. The trend over these years suggests some variability in the company's operating efficiency in utilizing its assets to generate operating profits.

Overall, Haemonetics Corporation's operating ROA indicates the company's ability to generate operating income relative to its total assets. It is important for the company to monitor and potentially improve this ratio to ensure optimal utilization of its assets and sustainable profitability in the future.